Discover Great Companies Discover Great Clients
Popularity  7326 Claim this company

Developer of small nucleic acid drugs for hepatitis B

No.653 Hangzhou Popularity Ranking No.115 Binjiang District Zhejiang No.2 Yao Li Yan Jiu No.4 Ren Yong Yi Miao No.5 Yi Chuan Xue No.5 Vaccines No.6 Yi Yao Xin Yao No.6 He Gan Acids No.6 Vaccines Technology No.8 Antibodies No.10 Xin Yao R&D No.10 Yuan Yan Yao No.10 Innovative Drugs Products No.13 Innovative Drugs
More

Company Overview

  • Nature: Joint Venture Size: 100-499 employees Founded: 7年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Hangzhou Haobo Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: C轮, 1.2亿美元。
  • Ranking: Ranked #653 in Hangzhou by popularity Ranked #2 in Hangzhou Yao Li Yan Jiu Company by popularity Ranked #4 in Hangzhou Ren Yong Yi Miao Company by popularity Ranked #5 in Hangzhou Yi Chuan Xue Company by popularity Ranked #5 in Hangzhou Vaccines Company by popularity
  • News: 2025-09-22:“浩博医药”完成6300万美元B2轮融资。
  • Salary: 67.2% of positions earn 20-50K, In 2026 vs last yearremained flat.。Master's salary: ¥29.8K, Doctorate salary: ¥2.5K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 54.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 23%, "Computer/Network/Technology": 11.5%。
  • Recruiting: In 2026 vs 2025remained flat. Demand for highly educated talent: Master's: 9.
  • Requirement: Education: 本科 leads with 55.6%. Experience: 5-10年 leads with 42.9%.
  • Region: Distributed across 1 regions, 杭州: 98.4%, 北京: 1.6%.

About the Company

[Summary] Developer of small nucleic acid drugs for hepatitis B

Haobo Pharmaceutical is a biopharmaceutical company dedicated to advancing oligonucleotide (small nucleic acid) drug innovation, starting with the goal of curing hepatitis B and committed to bringing transformative therapeutic solutions to patients worldwide.

As a leader in the third wave of biopharmaceuticals following small molecules and antibodies, Haobo Pharmaceutical has built a complete closed-loop system spanning target discovery, sequence design, process development, clinical development, and commercialization, leveraging its proprietary Med-Oligo™ technology platform and targeted delivery system. We not only focus on curing hepatitis B but have also extended our technology to multiple disease areas such as metabolic, genetic, and immune diseases, driving a paradigm shift in treatment from "long-term control" to "finite-course cure."

AHB-137, our core product, is one of the company's key pipelines in the field of hepatitis B cure. In 2024, it received "Breakthrough Therapy" designation from the National Medical Products Administration. Its Phase IIa data showed that AHB-137 monotherapy achieved a breakthrough 30% clinical cure rate in chronic hepatitis B patients after a 24-week treatment course. Enrollment for its Phase III clinical trial in mainland China has been completed, and multiple global Phase II clinical trials are progressing simultaneously.

Haobo Pharmaceutical has a first-class new drug R&D team with extensive operational experience. The core founder team were key leaders of the global team that developed breakthrough curative drugs for hepatitis C, bringing nearly two decades of successful R&D leadership philosophy and experience from multiple blockbuster drugs at Gilead Sciences in the United States. They successfully led the complete development of blockbuster drugs including Harvoni (annual sales exceeding ten billion US dollars), Epclusa (annual sales of several billion US dollars), and Biktarvy (all of which have been included in the national medical insurance scheme).

In 2026, as multiple platform pipelines enter clinical stages and core products move toward commercialization, Haobo Pharmaceutical is accelerating the construction of a full-chain innovation system from R&D to clinical development to commercialization, promoting the cluster development of China's small nucleic acid industry. We look forward to working with you to realize the vision of "from Chinese innovation to global accessibility."

For more information, please visit *.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Haobo Pharmaceutical Financing History (8 rounds)

Manage
C轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1.2亿美元
  • Investor: 汉康资本,夏尔巴投资,In...

Haobo Pharmaceutical How Fast Is Hiring Growing? (25 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 238%
  • 2024: Down 19%
  • 2023: Up 78%
  • 2022: Down 50%
Haobo Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Haobo Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Master's 9
Note: How fast is hiring at Hangzhou Haobo Pharmaceutical Co., Ltd. growing? Haobo Pharmaceutical2026: 44 openings (flat), 2025: 44 openings (up 238%), 2024: 13 openings (down 19%), 2023: 16 openings (up 78%), 2022: 9 openings (down 50%), 2021: 18 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Haobo Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hangzhou Haobo Pharmaceutical Co., Ltd.? Based on an analysis of Haobo Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 54.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 23%, "Computer/Network/Technology": 11.5%, "Other (R&D and Technical)": 8.2%, "Electronics/Electrical/Communication Technology": 6.6%, "Scientific Research": 1.6%. For reference only.

Haobo Pharmaceutical — What Are the Salaries Like? (61 records)

Manage
Haobo Pharmaceutical Salary Overview
salary range: 2K - 50K, 67.2% of roles pay ¥20-50K
Note: salary statistics are based on 61 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hangzhou Haobo Pharmaceutical Co., Ltd.?Haobo Pharmaceutical67.2% of positions earn 20-50K, Undergraduate salary: ¥。Hangzhou salary ranking top 10,医疗卫生/美容保健类 average salary ¥24.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Job Category

  • 医疗卫生/美容保健类
    55.6% of total 55.6%
  • 生物/制药/化工/环保类
    22.2% of total 22.2%
  • 工厂生产类
    14.3% of total 14.3%
  • 经营管理类
    12.7% of total 12.7%

Education

  • 本科
    55.6% of total 55.6%
  • 硕士
    27% of total 27%
  • 不限
    14.3% of total 14.3%
  • 大专
    1.6% of total 1.6%

Experience

  • 5-10年
    42.9% of total 42.9%
  • 1-3年
    25.4% of total 25.4%
  • 3-5年
    25.4% of total 25.4%
  • 不限
    6.3% of total 6.3%
View Detailed Analysis

What does Hangzhou Haobo Pharmaceutical Co., Ltd. require? Who is Haobo Pharmaceutical hiring? Haobo Pharmaceutical recruitment: 医疗卫生/美容保健类占比最多占55.6%,其次是生物/制药/化工/环保类占22.2%. What education can get in at Haobo Pharmaceutical? 本科占比最多占55.6%,其次是硕士占27%. High education required at Haobo Pharmaceutical? 硕士占27%,博士占1.6%. Work experience required at Haobo Pharmaceutical? 5-10年占比最多占42.9%,其次是1-3年占25.4%. Where are the job locations at Haobo Pharmaceutical? 杭州占比最多占98.4%,其次是北京占1.6%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 30,000万(元)
Legal Representative: 程国锋
Date Established:
Credit Code: 91330108MA2GPAWC0B
Registered Address: 浙江省杭州市滨江区长河街道滨安路688号5幢25层2501室

Partners & Suppliers

为浩博医药提供药物研发外包服务 Source
供应商 CRO服务
联合开展药物研发合作 Source
供应商 高校合作
为浩博医药提供临床试验服务 Source
供应商 临床试验服务
为浩博医药提供药物研发外包服务 Source
供应商 CRO服务

People who follow Haobo Pharmaceutical also follow

Haobo Pharmaceutical Competitors (Similar Companies)

物业 社区管理 实业投资
“Continuously innovating to bring patients medicines that significantly”
“Provider of solutions for global public safety and intelligent transpo”
水暖卫浴 制冷配件 燃气系统 市政
咨询 劳务外包 创新服务 企业服务
“Mobile Internet Information Security Provider”
国内电商 电子商务 制造业 智能制造/生产/加工
“High-quality dataset production and operation service provider”
“中国汽车修理教育界的航空母舰”
“Providing investors with professional risk management and wealth manag”
家用梯 液晶显示/LCD 驱动控制 电气控制系统
物业 商业物业 工业物业 保洁
咨询 管理咨询 企业管理 项目管理咨询
“Global payment solutions”
门窗 塑胶 塑料管 塑料门

Discover Great Companies, Discover Great Clients

杭州公司名录 杭州“Binjiang District”公司名录 杭州“医药”公司名录 杭州“疫苗”公司名录 杭州“新药研发”公司名录 杭州“创新药”公司名录 杭州“药物研发”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates